Our open access, online journal, ESMO Open is now listed in Pubmed Central, only 10-months after launch. Learn more about the journal!
Read the Editor's choice articles
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
ESMO’s flagship scientific journal, Annals of Oncology, publishes editorials, reviews, original articles and letters related to oncology
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Dr. Marco Merlano comments on the findings from the KEYNOTE-048 trial and an academic trial comparing bio-radiotherapy with chemo-radiotherapy in oropharyngeal cancer presented at ESMO 2018 Congress.
16 Nov 2018
It is intended for the treatment of non-metastatic castration resistant prostate cancer
14 Nov 2018
As a condition of accelerated approval, further studies are required
13 Nov 2018
A comprehensive new edition presents the latest information in localised, locally advanced and metastatic disease
13 Nov 2018
The European Society for Medical Oncology (ESMO) has selected Prof. Cornelis Melief to receive the 2018 ESMO Immuno-Oncology Award in recognition of...
12 Nov 2018
Newly published European Breast Guidelines,evidence-based recommendations
09 Nov 2018
Abscopal responses observed in tumours unresponsive to CTLA-4 blockade
Singapore
21 Nov
- 22 Nov
2018
Singapore
23 Nov
- 25 Nov
2018
Zurich, Switzerland
23 Nov
- 24 Nov
2018
Singapore
26 Nov
- 27 Nov
2018
Lausanne, Switzerland
30 Nov
- 01 Dec
2018
Geneva, Switzerland
13 Dec
- 16 Dec
2018
